1.
    发明专利
    未知

    公开(公告)号:AT361905T

    公开(公告)日:2007-06-15

    申请号:AT04803202

    申请日:2004-11-20

    Applicant: DEGUSSA

    Abstract: The present invention is concerned with the resolution of a mixture of enantiomers of N-protected amino acids by crystallization with enantiomerically pure N-unprotected &bgr;-amino acid derivatives.

    2.
    发明专利
    未知

    公开(公告)号:DE4425071A1

    公开(公告)日:1996-02-08

    申请号:DE4425071

    申请日:1994-07-15

    Applicant: DEGUSSA

    Abstract: Prodn. of optically active 3-hydroxypyrrolidines of formula (I) having high enantiomeric purity comprises reducing an enantiomerically pure 3-hydroxy-2,5-pyrrolidinedione of formula (II) with an activated alkali borohydride. R = H or OH; R = benzyl opt. ring-substd. by 1 or more alkyl, alkoxy and/or halo; * = asymmetric centre. (I) are intermediates for carbapenem antibiotics, see Chemotherapy 1991, 39 (Suppl. 3), 88 et seq., Tetrahedron Lett. 1984, 25 (26), 2793, JP04036282, JP 03275685 and Korean J. Med. Chem. 1993,3 (1), 72. (I) are also intermediates for optically active phosphanes useful as metal catalyst ligands in asymmetric hydrogenations, see Chem. Ber. 1986, 119, 3326, DE3446303, DE3403194 and Bull. Chem. Soc. Jpn. 1984, 57 (3), 823. In contrast to known reductive processes for the prodn. of (I) described in Chem. Ber. 1986, 119, 3327, JP 03200762, JP 01254657 and JP 01207266, the method is simple to perform and uses materials which are inexpensive and do not give rise to health or environmental problems. Yields are typically 52.1% to quantitative and enantiomeric purity is high (not quantified).

    6.
    发明专利
    未知

    公开(公告)号:DE602004006438T2

    公开(公告)日:2008-01-10

    申请号:DE602004006438

    申请日:2004-11-20

    Abstract: The present invention is concerned with the resolution of a mixture of enantiomers of N-protected amino acids by crystallization with enantiomerically pure N-unprotected &bgr;-amino acid derivatives.

    10.
    发明专利
    未知

    公开(公告)号:DE59810880D1

    公开(公告)日:2004-04-08

    申请号:DE59810880

    申请日:1998-07-18

    Applicant: DEGUSSA

    Abstract: Isolation of 1-ÄN -((S)-ethoxycarbonyl)-3-phenylpropyl)-N -trifluoroacetylÜ-L- lysyl-L-proline (I) (i.e. lisinoprilÄTFAÜ ethyl ester) from an aqueous solution obtained in the production of (I), comprises extraction followed by crystallisation. The novelty is that the solvent (or solvent mixture) used for extraction of (I) is also a major component of the solvent (mixture) used for crystallisation of (I). Also claimed is (I) which exhibits reflections at 6.7241, 9.4851, 11.9034, 16.3074 and 17.8722 (2&thetas; ).

Patent Agency Ranking